Monitoring afatinib treatment in HER2-positive gastric cancer with 18F-FDG and 89Zr-trastuzumab PET.
Janjigian YY; Viola-Villegas N; Holland JP; Divilov V; Carlin SD; Gomes-DaGama EM; Chiosis G; Carbonetti G; de Stanchina E; Lewis JS; Journal Of Nuclear Medicine: Official Publication, Society Of Nuclear Medicine, 2013, vol. 54, issue 6, p 936, ISSN 15355667. ISBN 15355667.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef